HB1169 — classify medetomidine as a Schedule III controlled substance and establish permissible uses.
What changed between bill versions as it moved through the Legislature.
This change converted the bill from its introduced form to its enrolled (final passed) version, with no substantive changes to the actual legislative content—the text classifying medetomidine as a Schedule III controlled substance and listing the five permissible uses remained identical, but formatting and procedural signature pages were added as required for enrollment.